Susquehanna Fundamental Investments’s Trueblue TBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-27,131
Closed -$518K 1474
2022
Q3
$518K Buy
+27,131
New +$549K 0.01% 1004
2022
Q1
$829K Buy
28,683
+9,451
+49% +$260K 0.02% 905
2021
Q4
$532K Sell
19,232
-5,046
-21% -$143K 0.01% 892
2021
Q3
$657K Buy
24,278
+9,764
+67% +$261K 0.01% 1074
2021
Q2
$408K Buy
14,514
+1,014
+8% +$27K 0.01% 1243
2021
Q1
$297K Hold
13,500
0.01% 1295
2020
Q4
$252K Hold
13,500
﹤0.01% 1300
2020
Q3
$209K Hold
13,500
0.01% 1181
2020
Q2
$206K Buy
+13,500
New +$200K 0.01% 835

Other funds holding TBI

Susquehanna Fundamental Investments's TBI Position: Q4 2022 in Review

Susquehanna Fundamental Investments sold out of Trueblue (TBI) in Q4 2022, closing a stake of 27,131 shares — an estimated $518K sold.

Susquehanna Fundamental Investments first reported a position in TBI in Q2 2020 and held it in 9 quarters. The position peaked at $829K in Q1 2022. 165 funds tracked by Wall St. Rank hold TBI as of Q4 2022.

  • Susquehanna Fundamental Investments reported no remaining Trueblue position as of Q4 2022 after selling out during the quarter.
  • Susquehanna Fundamental Investments sold 27,131 Trueblue shares in Q4 2022, an estimated $518K.
  • Susquehanna Fundamental Investments first reported a position in Trueblue in Q2 2020 and held it in 9 quarters.
  • Susquehanna Fundamental Investments's Trueblue position peaked at $829K in Q1 2022.
  • 165 funds tracked by Wall St. Rank held Trueblue as of Q4 2022.

Based on Susquehanna Fundamental Investments's 13F filing for Q4 2022, filed 14 Feb 2023.